Intrinsic resistance to EGFR tyrosine kinase inhibitors in advanced non-small-cell lung cancer with activating EGFR mutations

Overview of attention for article published in OncoTargets and therapy, June 2016

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 108 Dimensions

Readers on

mendeley: 89 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

Treatment of EGFR-driven cancer with fewer side effects

Grant US-11395821-B2

United States of America